TUCSON, Ariz., Jan. 18, 2018 (GLOBE NEWSWIRE) — Htg Molecular Diagnostics, Inc. (NASDAQ:HTGM) (HTG), a provider of instruments, reagents and services for molecular profiling applications, today announced the pricing of an underwritten public offering of 12,100,000 shares of its common stock at a price to the public of $2.90 per share. All of the shares are being sold by HTG. The gross proceeds from the offering are expected to be $35.1 million, before deducting the underwriting discounts and commissions and offering expenses. The offering is expected to close on January 23, 2018, subject to customary closing conditions. In addition, HTG […]